Opioid effectiveness and side effects in chronic pain (Q35627408)

9 August 2017

1 reference

title

Opioid effectiveness and side effects in chronic pain (English)

1 reference

9 August 2017

0 references

Paul J Christo

1

1 reference

9 August 2017

publication date

1 December 2003

1 reference

9 August 2017

published in

Anesthesiology Clinics

1 reference

9 August 2017

volume

21

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

699-713

1 reference

The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

The Edmonton staging system for cancer pain: preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Predictive factors in advanced cancer pain treated only by analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Individual variability in the response to different opioids: report of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Oral opioid therapy for chronic peripheral and central neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Opioid sensitivity of chronic pain: a patient-controlled analgesia method.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Use of methadone in a highly tolerant patient receiving parenteral hydromorphone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Kappa, but not mu or delta, opioids attenuate responses to distention of afferent fibers innervating the rat colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Evidence of a role for N-methyl-D-aspartate (NMDA) receptors in the facilitation of tail withdrawal after spinal transection.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Opioid poorly-responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Nimodipine fails to enhance the analgesic effect of slow release morphine in the early phases of cancer pain treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

The differential effects of morphine and the alpha 2-adrenoceptor agonists clonidine and dexmedetomidine on the prevention and treatment of experimental neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

The depressive effect of intrathecal clonidine on the spinal flexor reflex is enhanced after sciatic nerve section in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Dextromethorphan. An overview of safety issues

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Amantadine, a N-methyl-D-aspartate receptor antagonist, does not enhance postoperative analgesia in women undergoing abdominal hysterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Analgesic effects of dextromethorphan and morphine in patients with chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Potentiation of pentazocine analgesia by low-dose naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Outcome of chronic opioid therapy for non-cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Driving ability in cancer patients receiving long-term morphine analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

1 reference

7 January 2021

Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Opioids and akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Medical complications in methadone patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Heroin addiction: its relation to sexual behavior and sexual experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Galactorrhea-amenorrhea syndrome associated with heroin addiction.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

The effect of heroin addiction on pituitary-testicular function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Function of the Male Sex Organs in Heroin and Methadone Users

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Altered sexual function and decreased testosterone in patients receiving intraspinal opioids.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Hypogonadism in patients treated with intrathecal morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Outcome of intrathecal opioids in chronic non-cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Sex hormone suppression by intrathecal opioids: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

Evidence for multiple opioid receptors in the human posterior pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2803%2900087-7

7 January 2021

10.1016/S0889-8537(03)00087-7

Identifiers

DOI

1 reference

9 August 2017

1 reference